Welcome to our dedicated page for Ribbon Acquisition SEC filings (Ticker: RIBBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ribbon Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ribbon Acquisition's regulatory disclosures and financial reporting.
Ribbon Acquisition Corp. (RIBB) reports that its Extraordinary General Meeting of Shareholders, originally scheduled for September 14, 2026 at 10:00 a.m. Eastern Time, has been rescheduled to November 14, 2026 at 10:00 a.m. Eastern Time.
Only shareholders of record as of the close of business on February 18, 2026 remain entitled to vote at the Extraordinary General Meeting. Proxies already submitted will be voted at the adjourned meeting unless properly revoked, so shareholders who have previously voted do not need to take further action.
Ribbon Acquisition Corp. (RIBB) reported results of its September 10, 2026 Extraordinary General Meeting, where shareholders approved all eight proposals related to its proposed business combination with DRC Medicine and the domestication of the company from the Cayman Islands to Delaware. Shareholders approved amendments removing the US$5,000,001 net tangible asset redemption constraint, the domestication to Delaware, the Business Combination Agreement with DRC Medicine entities, new Pubco organizational documents, Nasdaq share issuance and incentive plan approvals, a 2026 Incentive Award Plan, the election of seven Pubco directors, and an adjournment authorization.
Holders of 3,460,471 ordinary shares elected to redeem for an aggregate of $36,646,387.89, or about $10.59 per share. After redemption reversals covering 30,633 shares, 3,429,838 shares remain subject to redemption for approximately $36,321,984.42, leaving about $1,411,594.05 in the trust account.
Ribbon Acquisition Corp. (symbol: RIBB) is the issuer of record for a Form 8-K filing submitted to the SEC.
Ribbon Acquisition Corp. reported that an aggregate of $125,000 (the “Extension Payment”) was deposited on August 11, 2026 into its trust account for the benefit of public shareholders. This payment allows the company to extend the deadline to complete its initial business combination by one month, from August 15, 2026 to September 15, 2026 (the “Extension”). The company remains listed on Nasdaq under the symbols RIBB (Class A ordinary shares), RIBBU (units), and RIBBR (rights).
Ribbon Acquisition Corporation, a Cayman Islands SPAC listed on Nasdaq, reports that as of June 30, 2026 it held $38.4 million in cash and marketable securities in its trust account and total assets of $38.5 million. Current assets outside the trust were minimal at $75,669, and current liabilities were $1.8 million, resulting in a working capital deficit of about $1.8 million.
For the six months ended June 30, 2026, Ribbon recorded net income of $233,154, driven by $649,551 of interest income on trust investments, offset by $416,397 of operating expenses. Class A ordinary shares subject to possible redemption totaled $35.1 million, reflecting redemptions of 1,436,867 public shares for $14.9 million at approximately $10.40 per share in January 2026.
The company has until January 16, 2027 to complete its initial business combination with DRC Medicine Ltd. and related parties, under a Business Combination Agreement valuing the target at an equity value of 350,000,000, with consideration shares determined by the SPAC’s redemption price. Management discloses that mandatory liquidation if no deal closes by the deadline, combined with limited working capital, raises substantial doubt about Ribbon’s ability to continue as a going concern. Subsequent extension deposits of $125,000 per month continue to be made into the trust.
Ribbon Acquisition Corp. deposited an aggregate $125,000 into its trust account for public shareholders. This Extension Payment allows the company to extend the period to consummate its initial business combination by one month, from July 15, 2026 to August 15, 2026.
Ribbon Acquisition Corp. is incorporated in the Cayman Islands, and its Class A ordinary shares, units and rights trade on The Nasdaq Stock Market under the symbols RIBB, RIBBU and RIBBR, respectively.
Ribbon Acquisition Corp. deposited $125,000 into its trust account to extend the deadline to complete its initial business combination by one month, moving the date from June 15, 2026 to July 15, 2026. This payment supports continued efforts to find and close a suitable merger target.
The company also received a notice from Nasdaq on June 9, 2026 confirming it has regained compliance with Nasdaq Listing Rule 5250(f) after paying a past due fee balance. Ribbon Acquisition is now in compliance with all applicable Nasdaq continued listing requirements, resolving the earlier non-compliance previously disclosed.
Ribbon Acquisition Corp. disclosed that Nasdaq has moved to delist its securities after the company failed to pay listing fees required under Nasdaq Listing Rule 5250(f), with a past-due balance of $75,000. The company has received a staff determination letter from Nasdaq’s Listing Qualifications Department and plans to appeal this decision to a Hearings Panel.
Requesting a hearing, which carries a $20,000 fee, would automatically stay the suspension of trading and the filing of Form 25‑NSE while the Panel reviews the case. The company must submit its hearing request by June 11, 2026 and is in discussions with Nasdaq, but it cautions there is no assurance it will succeed in maintaining its Nasdaq listing.
Ribbon Acquisition Corporation reported Q1 2026 net income of $252,755, driven by $330,541 of interest on trust investments against operating expenses of $77,786. As of March 31, 2026, the trust held $37,716,530 and cash outside the trust was $1,878.
The SPAC has $35,062,690 of Class A shares classified as redeemable and a working capital deficit of $1,008,960, and management highlights substantial doubt about its ability to continue as a going concern if a business combination is not completed by January 16, 2027. The company continues to pursue its previously signed Business Combination Agreement with DRC Medicine and funded extension payments via a $600,000 related-party promissory note.
Ribbon Acquisition Corp ownership update: Polar Asset Management Partners Inc., as investment adviser to Polar Multi-Strategy Master Fund, reports beneficial ownership of 100,000 Class A Ordinary Shares (CUSIP G7552W109), representing 2.1% of the class. The filing is an Amendment No. 1 to a Schedule 13G and is signed by the fund's Chief Compliance Officer on 05/15/2026. The statement notes Ownership of 5 Percent or Less of a Class.